Di Bella Santina, Cannella Vincenza, Mira Francesco, Di Marco Patrizia, Lastra Antonio, Gucciardi Francesca, Purpari Giuseppa, Guercio Annalisa
Instituto Zooprofilattico Sperimentale della Sicilia "A. Mirri", via G. Marinuzzi 3, 90129 Palermo, Italy.
Animals (Basel). 2021 Jun 11;11(6):1755. doi: 10.3390/ani11061755.
Mesenchymal stem cells (MSCs) are used in therapy in animal models and veterinary medicine, due to their capacity of inducing tissue regeneration and immunomodulation. Their clinical application requires a ready off-the-shelf amount of viable therapeutics doses. For this purpose, it is useful to cryopreserve MSCs to gain a ready and controlled source of abundant autologous stem cells. We evaluated the effect of 7 years cryopreservation using 10% dimethyl sulfoxide (DMSO) with different fetal bovine serum (FBS) concentrations (from 10 to 90%) on different passages of MSCs isolated from canine adipose tissue (cAD-MSCs). The study aimed to evaluate the most adequate cell passage and FBS percentage for the long-term cryopreservation of cells by maintaining the stemness features. Phenotype morphology, cell viability, osteogenic and adipogenic differentiation potentials, proliferative potential and expression of pluripotency markers were analyzed in thawed cells and compared with fresh ones. We demonstrated that cells cryopreserved with at least 80% FBS maintain unaltered the stemness characteristics of the freshly isolated cells. In particular, cells of P0-P1 passages have to be expanded in vitro and subsequently cryopreserved and cells of P2-P4 passages should be considered in the studies on therapeutic application and in vitro study of cAD-MSCs.
间充质干细胞(MSCs)因其诱导组织再生和免疫调节的能力,已被用于动物模型治疗和兽医学中。其临床应用需要现成的、可立即使用的有效治疗剂量。为此,冷冻保存MSCs以获得现成且可控的丰富自体干细胞来源很有用。我们评估了使用10%二甲基亚砜(DMSO)和不同浓度胎牛血清(FBS,从10%到90%)对从犬脂肪组织分离的MSCs(cAD-MSCs)不同传代细胞进行7年冷冻保存的效果。该研究旨在通过维持干性特征来评估用于细胞长期冷冻保存的最合适细胞传代和FBS百分比。对解冻后的细胞分析其表型形态、细胞活力、成骨和成脂分化潜能、增殖潜能以及多能性标志物的表达,并与新鲜细胞进行比较。我们证明,用至少80% FBS冷冻保存的细胞能保持新鲜分离细胞的干性特征不变。特别是,P0-P1代的细胞必须在体外扩增,随后进行冷冻保存,而P2-P4代的细胞应在cAD-MSCs的治疗应用研究和体外研究中予以考虑。